Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia

Title
Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia
Authors
Keywords
MAPK signaling cascades, Cancer treatment, Mouse models, Point mutation, Cholesterol, Cytometry, Cell viability testing, Leukemia cells
Journal
PLoS One
Volume 12, Issue 7, Pages e0179558
Publisher
Public Library of Science (PLoS)
Online
2017-07-19
DOI
10.1371/journal.pone.0179558

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now